On June 30th, CDC Director Rochelle P. Walensky, M.D., M.P.H., announced her adoption of the Advisory Committee on Immunization Practices’ (ACIP) recommendation to preferentially recommend the use of specific flu vaccines for adults 65 years and older, including higher dose and adjuvanted flu vaccines. The preference applies to Fluzone High-Dose Quadrivalent, Flublok Quadrivalent and Fluad Quadrivalent flu vaccines. More: https://www.cdc.gov/flu/prevent/qa_fluzone.htm